Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure

• Autores: Gregg C. Fonarow, Ali Ahmed
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 11, 2013, págs. 1107-1108
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • In a propensity-matched cohort of patients with heart failure with preserved ejection fraction (HFPEF), Dr Lund and colleagues reported that the use of renin-angiotensin system (RAS) antagonists (angiotensin-converting enzyme [ACE] inhibitors or angiotensin II receptor blockers) was associated with lower all-cause mortality.